I am a passionate scientific researcher bridging the gap between cutting-edge research and tangible clinical solutions. As a cofounder of Baxiva, I am working on the development of innovative glycoconjugate vaccines tailored to combat gram-negative bacteria. Specifically, I am specialized in the business development of our startup as we prepare for clinical steps. Our mission is not just to create vaccines but to revolutionize preventive healthcare by offering effective solutions to global health challenges. I am thrilled about the prospect of bringing our groundbreaking vaccine to market, knowing that it has the potential to transform lives and shape the future of healthcare.